Gene · 79001
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry. | Blood Adv | 2024 | 39163621 | PubTator, text mining | PubMed |
| Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function. | Pharmazie | 2024 | 39152554 | PubTator, text mining | PubMed |
| Conceptual frameworks for the integration of genetic and social epidemiology in complex diseases. | Glob Epidemiol | 2024 | 39104369 | PubTator, text mining | PubMed |
| Correlation between Metabolic Parameters and Warfarin Dose in Patients with Heart Valve Replacement of Different Genotypes. | Rev Cardiovasc Med | 2024 | 39076565 | PubTator, text mining | PubMed |
| Correction to "Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals". | Clin Pharmacol Ther | 2024 | 39039894 | PubTator, text mining | PubMed |
| How nurses face a new era of genomics medicine and precision health: Oncology nurse clinicians' perspective. | Asia Pac J Oncol Nurs | 2024 | 39006319 | PubTator, text mining | PubMed |
| Using electronic health records for clinical pharmacology research: Challenges and considerations. | Clin Transl Sci | 2024 | 38943244 | PubTator, text mining | PubMed |
| Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method. | Sci Rep | 2024 | 38937509 | PubTator, text mining | PubMed |
| Stability of Anticoagulation Following Acenocoumarin in Stroke Patients: Role of Pharmacogenomics and Acquired Factors. | Ann Indian Acad Neurol | 2024 | 38907686 | PubTator, text mining | PubMed |
| Warfarin analogs target disulfide bond-forming enzymes and suggest a residue important for quinone and coumarin binding. | J Biol Chem | 2024 | 38762182 | PubTator, text mining | PubMed |
| Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort. | Pharmacotherapy | 2024 | 38686648 | PubTator, text mining | PubMed |
| Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants. | Genes (Basel) | 2024 | 38674455 | PubTator, text mining | PubMed |
| Is a Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism a Risk Factor for Nephrolithiasis in Sarcoidosis? | Int J Mol Sci | 2024 | 38674033 | PubTator, text mining | PubMed |
| Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR. | Clin Pharmacol Ther | 2024 | 38655898 | PubTator, text mining | PubMed |
| Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial. | Ann Hematol | 2024 | 38634917 | PubTator, text mining | PubMed |
| [Advances in warfarin's anticoagulation therapy in Chinese population after mechanical valve replacement]. | Zhonghua Wai Ke Za Zhi | 2024 | 38548617 | PubTator, text mining | PubMed |
| VKORC1 polymorphisms and complete resistance to vitamin K antagonists: About two cases. | Biomedicine (Taipei) | 2024 | 38533299 | PubTator, text mining | PubMed |
| COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment. | J Thromb Thrombolysis | 2024 | 38526751 | PubTator, text mining | PubMed |
| Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma. | J Cell Mol Med | 2024 | 38520221 | PubTator, text mining | PubMed |
| A physiologically-based pharmacokinetic/pharmacodynamic modeling approach for drug-drug-gene interaction evaluation of S-warfarin with fluconazole. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38487942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79001/papers?page=7